SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001326732-24-000017
Filing Date
2024-04-24
Accepted
2024-04-24 16:05:52
Documents
22
Period of Report
2024-04-24

Document Format Files

Seq Description Document Type Size
1 DEF 14A xncr-20240423.htm   iXBRL DEF 14A 949973
6 xncr-20240423_g1.jpg GRAPHIC 17323
7 xncr-20240423_g2.jpg GRAPHIC 5608
8 xncr-20240423_g3.jpg GRAPHIC 767
9 xncr-20240423_g4.jpg GRAPHIC 28178
10 xncr-20240423_g5.jpg GRAPHIC 29261
11 xncr-20240423_g6.jpg GRAPHIC 150815
12 xncr-20240423_g7.jpg GRAPHIC 172219
13 xncr-20240423_g8.jpg GRAPHIC 114076
  Complete submission text file 0001326732-24-000017.txt   2778603

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT xncr-20240423.xsd EX-101.SCH 2500
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT xncr-20240423_def.xml EX-101.DEF 2709
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT xncr-20240423_lab.xml EX-101.LAB 3088
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT xncr-20240423_pre.xml EX-101.PRE 1771
25 EXTRACTED XBRL INSTANCE DOCUMENT xncr-20240423_htm.xml XML 57870
Mailing Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107
Business Address 465 N. HALSTEAD ST. SUITE 200 PASADENA CA 91107 626-305-5900
Xencor Inc (Filer) CIK: 0001326732 (see all company filings)

IRS No.: 201622502 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36182 | Film No.: 24870566
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)